Responsibilities

• Build UCB's Alzheimer's disease knowledge and translate patient, caregiver, stakeholder, diagnostic, access, and competitive insights into asset choices.
• Lead the global cross-functional forum for learning, collaboration and commercial decision making.
• Develop the patient population and indication vision, value proposition, positioning, and commercialization strategy.
• Define the market-development priorities required to support future adoption, including diagnosis, biomarkers, referral and treatment pathways, healthcare infrastructure, and care delivery.
• Develop market assessments, forecasts, business cases, and commercialization scenarios, including key assumptions, uncertainties, and capability needs.
• Support evaluation of development and partnering scenarios through commercial assessment of strategic options, assumptions, opportunities, and risks.
• Bring external stakeholder perspectives into asset decisions and translate the work into clear recommendations for the Asset team.

Requirements

• Bachelor’s degree.
• 10+ years of pharmaceutical strategy, marketing, or commercialization experience.
• 2+ years direct Alzheimer’s disease or dementia experience.
• 2+ years experience supporting a development-stage, post-proof-of-concept, or pre-launch asset.

Preferred

• Experience developing market assessments, forecasts, scenarios, or business cases
• Strong understanding of Alzheimer’s diagnosis, biomarkers, stakeholders, and treatment pathways.
• U.S. pharmaceutical commercialization experience.
• Global pharmaceutical strategy or commercialization experience.
• Experience supporting partnered or co-development assets.
• Strong business judgment and ability to synthesize incomplete information.
• Demonstrated success leading through influence across functions and geographies.